Overview Dividends

(LEN) Lennar - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US5260571048

Single-Family Homes, Multifamily Rentals, Mortgage Financing, Land Development

Homebuilding
Market Cap in USD: 25,954m

IPO / Inception: 1987-11-05
Return 12m vs S&P 500: -25.5%

EPS (Earnings per Share)

EPS CAGR: 5.01%
EPS Trend: -30.3%

Last SUE: -0.80
Qual. Beats: 0

Revenue

Rev. CAGR: 11.60%
Rev. Trend: 31.4%

Last SUE: 0.52
Qual. Beats: 0

Dividends

Dividend Yield	6.67%
Yield on Cost 5y	10.86%
Yield CAGR 5y	33.75%
Payout Consistency	87.4%
Payout Ratio	16.4%

Risk via 5d forecast
Volatility	33.5%
Value at Risk 5%th	53.7%
Relative Tail Risk	-2.66%

Reward TTM
Sharpe Ratio	-0.32
Alpha	-25.74
CAGR/Max DD	0.28

Character TTM
Hurst Exponent	0.429
Beta	0.672
Beta Downside	0.372

Drawdowns 3y
Max DD	39.27%
Mean DD	13.99%
Median DD	10.08%

Description: LEN Lennar December 17, 2025

Lennar Corporation (NYSE:LEN) is the largest U.S. homebuilder, operating under the Lennar brand across five regional homebuilding segments (East, Central, Texas, West, and Other) as well as Financial Services, Multifamily, and ancillary businesses. Its core activities include constructing and selling single-family attached and detached homes, developing residential land, and managing multifamily rental properties, while also providing mortgage financing, title, insurance, and closing services, and originating commercial mortgage-backed securities.

Key recent metrics illustrate the scale and market exposure of the business: FY 2023 revenue reached approximately $27.6 billion with a net income of $2.4 billion, and the company reported a home-sales backlog of roughly $30 billion, equivalent to about 12 months of pipeline at current build rates. Average selling prices have risen to roughly $400 k, driven by limited inventory and higher construction costs, while the U.S. housing-starts index and mortgage-rate volatility remain primary macro drivers of demand and profitability.

For a deeper dive into LEN’s valuation metrics and scenario analysis, you might explore the ValueRay platform.

Piotroski VR‑10 (Strict, 0-10) 6.0

Net Income (2.08b TTM) > 0 and > 6% of Revenue (6% = 2.05b TTM)

FCFTA -0.02 (>2.0%) and ΔFCFTA -11.37pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)

NWC/Revenue 37.49% (prev 53.90%; Δ -16.40pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)

CFO/TA -0.02 (>3.0%) and CFO -568.2m <= Net Income 2.08b (YES >=105%, WARN >=100%)

Net Debt (617.4m) to EBITDA (2.91b) ratio: 0.21 <= 3.0 (WARN <= 3.5)

Current Ratio 4.89 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)

Outstanding Shares last Quarter (252.4m) change vs 12m ago -5.57% (target <= -2.0% for YES)

Gross Margin 17.62% (prev 22.59%; Δ -4.98pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)

Asset Turnover 90.13% (prev 85.87%; Δ 4.26pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)

Interest Coverage Ratio 18.04 (EBITDA TTM 2.91b / Interest Expense TTM 118.1m) >= 6 (WARN >= 3)

Altman Z'' 6.87

(A) 0.37 = (Total Current Assets 16.09b - Total Current Liabilities 3.29b) / Total Assets 34.43b

(B) 0.65 = Retained Earnings (Balance) 22.47b / Total Assets 34.43b

(D) 1.83 = Book Value of Equity 22.51b / Total Liabilities 12.29b

Total Rating: 6.87 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 53.30

1. Piotroski 6.0pt

2. FCF Yield -2.68%

3. FCF Margin -2.09%

4. Debt/Equity 0.19

5. Debt/Ebitda 0.21

6. ROIC - WACC (= -1.71)%

7. RoE 9.25%

8. Rev. Trend 31.41%

9. EPS Trend -30.33%

What is the price of LEN shares?

As of December 29, 2025, the stock is trading at USD 104.90 with a total of 1,868,289 shares traded.
Over the past week, the price has changed by -1.95%, over one month by -20.11%, over three months by -17.49% and over the past year by -11.49%.

Is LEN a buy, sell or hold?

Lennar has received a consensus analysts rating of 3.48. Therefor, it is recommend to hold LEN.

Strong Buy: 4
Buy: 2
Hold: 15
Sell: 0
Strong Sell: 0

What are the forecasts/targets for the LEN price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	114.9	9.5%
Analysts Target Price	114.9	9.5%
ValueRay Target Price	112.4	7.1%

LEN Fundamental Data Overview December 27, 2025

Market Cap USD = 25.95b (25.95b USD * 1.0 USD.USD)
P/E Trailing = 13.1692
P/E Forward = 12.21
P/S = 0.7592
P/B = 1.1819
P/EG = 2.3617
Beta = 1.401
Revenue TTM = 34.13b USD
EBIT TTM = 2.13b USD
EBITDA TTM = 2.91b USD
Long Term Debt = 6.10b USD (from longTermDebt, last fiscal year)
Short Term Debt = 265.5m USD (from shortTermDebt, two quarters ago)
Debt = 4.08b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 617.4m USD (from netDebt column, last quarter)
Enterprise Value = 26.57b USD (25.95b + Debt 4.08b - CCE 3.47b)
Interest Coverage Ratio = 18.04 (Ebit TTM 2.13b / Interest Expense TTM 118.1m)
FCF Yield = -2.68% (FCF TTM -713.0m / Enterprise Value 26.57b)
FCF Margin = -2.09% (FCF TTM -713.0m / Revenue TTM 34.13b)
Net Margin = 6.09% (Net Income TTM 2.08b / Revenue TTM 34.13b)
Gross Margin = 17.62% ((Revenue TTM 34.13b - Cost of Revenue TTM 28.12b) / Revenue TTM)
Gross Margin QoQ = 16.29% (prev 17.67%)
Tobins Q-Ratio = 0.77 (Enterprise Value 26.57b / Total Assets 34.43b)
Interest Expense / Debt = 1.21% (Interest Expense 49.3m / Debt 4.08b)
Taxrate = 27.10% (185.1m / 683.0m)
NOPAT = 1.55b (EBIT 2.13b * (1 - 27.10%))
Current Ratio = 4.89 (Total Current Assets 16.09b / Total Current Liabilities 3.29b)
Debt / Equity = 0.19 (Debt 4.08b / totalStockholderEquity, last quarter 21.96b)
Debt / EBITDA = 0.21 (Net Debt 617.4m / EBITDA 2.91b)
Debt / FCF = -0.87 (negative FCF - burning cash) (Net Debt 617.4m / FCF TTM -713.0m)
Total Stockholder Equity = 22.46b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.04% (Net Income 2.08b / Total Assets 34.43b)
RoE = 9.25% (Net Income TTM 2.08b / Total Stockholder Equity 22.46b)
RoCE = 7.46% (EBIT 2.13b / Capital Employed (Equity 22.46b + L.T.Debt 6.10b))
RoIC = 5.75% (NOPAT 1.55b / Invested Capital 27.03b)
WACC = 7.46% (E(25.95b)/V(30.04b) * Re(8.49%) + D(4.08b)/V(30.04b) * Rd(1.21%) * (1-Tc(0.27)))
Discount Rate = 8.49% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -4.97%
Fair Price DCF = unknown (Cash Flow -713.0m)
EPS Correlation: -30.33 | EPS CAGR: 5.01% | SUE: -0.80 | # QB: 0
Revenue Correlation: 31.41 | Revenue CAGR: 11.60% | SUE: 0.52 | # QB: 0
EPS next Quarter (2026-02-28): EPS=0.95 | Chg30d=-0.621 | Revisions Net=-4 | Analysts=8
EPS current Year (2026-11-30): EPS=7.10 | Chg30d=-1.832 | Revisions Net=-5 | Growth EPS=-11.9% | Growth Revenue=-1.4%
EPS next Year (2027-11-30): EPS=9.87 | Chg30d=-1.933 | Revisions Net=-2 | Growth EPS=+39.1% | Growth Revenue=+7.6%

Additional Sources for LEN Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle